ISSN 1415-790X versión impresa
ISSN 1980-5497 versión on-line



Scope and policy

The Brazilian Journal of Epidemiology aims at publishing not previously published Original Articles (maximum of 21,600 characters), including critical reviews about a specific subject, which contribute with the knowledge and development of Epidemiology and related sciences. Only Systematic Reviews and Meta-Analyses will be accepted; Integrative Reviews will not be accepted.

It also publishes articles in the following sections:

  • Original Articles with research results
  • Methodologic: Papers that analyze the different techniques used in epidemiological studies;
  • Debate: Aims at discussing different views of the same subject, which can be presented as a consensus/dissensus, original article followed by comments of other authors, reproduction of round tables and other similar forms;
  • Notes and Information: previous notes of investigation papers, as well as brief reports of new aspects of epidemiology, besides news regarding events in the field, new books and others (maximum of 6,450 characters);
  • Letters to the Editor: comments of readers about the papers published in the Brazilian Journal of Epidemiology (from 3,260 to 4,570 characters).

The manuscripts presented should be exclusive addressed to the Brazilian Journal of Epidemiology; its simultaneous presentation to another journal is not allowed. After the opinions are sent, the authors have to sign a declaration, according to the model provided by RBE (Declaration of Exclusivity, Declaration of Copyrights and Declaration of Conflict of Interests). The authors are entirely responsible for the concepts issued in any of the sections of the Journal.

The Journal is in charge of the published manuscripts, and it is forbidden to reproduce it – even if partially – in other journals, as well as to translate it to another language without the previous consent of the Editorial Board. Therefore, after the approval for publication, all papers should also have a copyright transfer agreement signed by the authors, according to the model provided by the Journal in advance.

Each manuscript is analyzed by at least two evaluators, indicated by one of the Associated Editors, who will elaborate a final and conclusive report to be submitted to the Scientific Editor. In the first of submission, the secretariat verifies if all of the criteria were met, and contacts the author. The manuscript is sent for the editors’ appreciation only if it meets all of the requirements established by RBE.

The Brazilian Journal of Epidemiology does not charge fees for the submission of papers, nor to evaluate or publish them.

Approval by the Research Ethics Committee (CEP)
This requirement has been present since RBE started being published, and we reassure it now, demanding special reference in the texts. This demand can be dismissed in some types of studies that use only aggregate data, without identifying the subjects, available in databases and common in the health field. No instance is better than a CEP to analyze the nature of the investigation proposals, according to the orientation of the National Ethics Research Commission (CONEP/CNS/MS). The CEP that approves the investigation must be registered in CONEP.

The following Resolutions should be contemplated:

  • 196/96, reformulated by 446/11, about Guidelines and Regulatory Rules of Research Involving Human Subjects;
  • 251/97, about Rules of Research Involving Human Subjects for the field of Research with New Drugs, Medication, Vaccines and Diagnostic Tests;
  • 292/99 and the Regulation of August, 2002, concerning the special thematic field of Research Coordinated from Foreign Countries, or with Foreign Participation, and Research Involving the Shipping of Biological Material Abroad.

The Brazilian Journal of Epidemiology supports the policies from the World Health Organization (WHO) and the International Committee of Medical Journal Editors (ICMJE) to register clinical trials, recognizing the importance of these initiatives for the registration and international publication of information on clinical trials, with open access. Therefore, after 2007, only the papers of clinical research that have received an identification number in one of the Clinical Trial Records validated by the criteria established by WHO and ICMJE were accepted for publication; their addresses are available in the website of ICMJE. The identification/approval number must be registered in the title page. 

The institutions that register clinical trials according to ICMJE criteria are:

  • Australian New Zealand Clinical Trials Registry (ANZCTR)
  • International Standard Randomised Controlled Trial Number (ISRCTN)
  • Nederlands Trial Register (NTR)
  • UMIN Clinical Trials Registry (UMIN-CTR)
  • WHO International Clinical Trials Registry Platform (ICTRP)


Presentation of the manuscript

Manuscripts are accepted in Portuguese, Spanish or English. Articles in Portuguese and Spanish must contain an abstract in the original language of the paper, besides the English version. Papers in English must include the abstract in the original language of the article, besides the abstract in Portuguese.

The manuscript must include the letter to the editor in a separate file, justifying the possible publication.

Manuscripts must have 21,600 characters at most and 5 illustrations, including Introduction, Methodology, Results, Discussion, Conclusion (Title page, Bibliographic References and Illustrations are not included in this count). The file must come in the following order: Title Page, Introduction, Methodology, Results, Discussion, Conclusion, Bibliographic References and Illustrations. The manuscript must be structured with the following section, in order: Title page, Resumo, Abstract, Introduction, Methodology, Results, Discussion, Conclusion, References and Illustrations. The complete final file (title page, sections, references and illustrations) must be submitted in the DOC format (Microsoft Word), and the tables must be sent in an editable format (Microsoft Word or Excel), according to the following formatting:

  • Margins configured to “Normal” in the entire text (superior and inferior = 2.5 cm; left and right = 3 cm);
  • Double space in the entire text;
  • Font: Times New Roman, 12, in the entire text;
  • No line breaks;
  • No forced manual hyphenation.


Title Page
The authors must provide the titles of the manuscript in Portuguese and in English (maximum of 140 characters), short title (maximum of 60 characters), authors’ data*, corresponding author’s data (full name, address and e-mail), acknowledgements, existence or lack of conflicts of interest, financing and identification/approval number in the Research Ethics Committee. The individual collaboration of each author in the elaboration of the manuscript must be specified.

* The SciELO index requires the precise identification of the authors’ affiliation, which is essential to obtain different bibliometric indicators. The identification of each author’s affiliation must be restricted to names of institutional organizations, City, State and Country (without the titles of the authors).

Financing must be informed in the Title page. In case the study does not have contact with institutional and/or private resources, the authors must inform that the study was not financed.

The Acknowledgments must have 460 characters at most.

Resumo and Abstract
The abstracts must contain 1,600 characters, at most, and must be presented in a structured form, contemplating the sections: Introduction, Methodology, Results, Discussion, Conclusion. The same rules apply to resumo.
The authors must present a minimum of 3 and a maximum of 6 keywords, as well as their respective versions in Portuguese, considered as descriptors of the paper content, in the language of the article and in English. These descriptors must be standardized according to DeCS (

The tables and figures (graphs and images) must be inserted at the end of the manuscript; they must not be sent in separate pages. They have to be sufficiently clear to allow its reduced reproduction, when necessary. Provide titles in Portuguese and in English, outside the illustrations (the internal part of the table and graphs do not need to be in English). There should be a break line in between them, respecting the maximum number of 5 pages dedicated to Tables, Graphs and Figures. These should be presented after the References, at the end of the manuscript (in a single file).

Illustrations can have 15 cm in length, at most, and must be presented within the requested margins (configuration named by Word as “Normal”). Illustrations that exceed the established margin will not be accepted.


  • Providing high-resolution pictures
  • Providing editable graphs (preferably PDF).

Tables, Equations, Charts and Flow charts

  • Always send in an editable file (Word or Excel), never an image;
  • Do not format tables using TAB; use the software table tool;
  • In the tables, separate the columns in other cells (of the new column); do not use spaces for divisions.

When mentioned for the first time, they should come with the full name. Abbreviations cannot be used in the title or in the abstract.

They should be consecutively numbered, according to the first time it is mentioned in the text, using Arabic numerals. The final list must contain the numerical order of the text, ignoring the alphabetical order of the authors. Titles of books, publishers or others must not be abbreviated. Journal titles will be in accordance with the abbreviations in the Medicus/Medline Index. The names of the 6 first authors have to be included, followed by the expression et al. when there are more authors. Personal communications, papers that have never been printed or ongoing papers can be mentioned when absolutely necessary, but they should not be included in the reference list; these should be presented in the text or in a footnote. When an article is about to be published, the following must be indicated: journal title, year and other available data, followed by the expression “in press” between parenthesis. Publications that are unconventional or hard to access can be mentioned as long as the authors explain to the readers where to find them. The authors are responsible for the accuracy of the references.


Papers in journals
Szklo M. Estrogen replacement therapy and cognitive functioning in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 1996; 144: 1048-57.

Books and other theses
Lilienfeld DE, Stolley PD. Foundations of epidemiology. New York: Oxford University Press; 1994.

Book chapter
Laurenti R. Medida das doenças. In: Forattini OP. Ecologia, epidemiologia e sociedade. São Paulo: Artes Médicas; 1992. p. 369-98.

Thesis and Dissertation
Bertolozzi MR. Pacientes com tuberculose pulmonar no Município de Taboão da Serra: perfil e representações sobre a assistência prestada nas unidades básicas de saúde [dissertação de mestrado]. São Paulo: Faculdade de Saúde Pública da USP; 1991.

Congress paper or similar (published)
Mendes Gonçalves RB. Contribuição à discussão sobre as relações entre teoria, objeto e método em epidemiologia. In: Anais do 1º Congresso Brasileiro de Epidemiologia; 1990 set 2-6; Campinas (Br). Rio de Janeiro: ABRASCO; 1990. p. 347-61.

WHO report
World Health Organization. Expert Committee on Drug Dependence. 29th Report. Geneva; 1995. (WHO - Technical Report Series, 856).

Electronic Documents
Hemodynamics III: the ups and downs of hemodynamics. [computer program]. Version 2.2. Orlando (FL): Computorized Systems; 1993.


The Brazilian Journal of Epidemiology adopts the rules of the International Committee of Medical Journal Editors (Vancouver style), published in the New England Journal of Medicine, 1997; 336: 309, and in Revista Panamericana de Salud Publica, 1998; 3: 188-96 (


Sending of manuscripts

Manuscripts are submitted online, using the SciELO platform (


[Home] [About this journal] [Editorial board] [Subscription]

Creative Commons License All the content of the journal, except where otherwise noted, is licensed under a Creative Commons License

Associação Brasileira de Pós - Graduação em Saúde Coletiva
Av. Dr. Arnaldo, 715 - 2º andar - sl. 3 - Cerqueira César
01246-904 São Paulo SP Brasil
Tel./FAX: +55 11 3085-541